Try Fund Library Premium
For Free with a 30 day trial!
Alternative Other
Close (09-19-2025) |
$81.64 |
---|---|
Change |
-$2.83
(-3.35%)
|
Open | $83.27 |
---|---|
Day Range | $81.61 - $83.57 |
Volume | 4,770 |
As at August 31, 2025
As at June 30, 2025
Inception Return (September 26, 2022): 48.41%
Row Heading | Return | Annualized Return | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
Fund | 15.09% | 68.43% | 85.43% | 24.04% | 75.53% | 61.91% | - | - | - | - | - | - | - | - |
Benchmark | 4.96% | 9.85% | 14.09% | 17.59% | 25.86% | 22.26% | 17.49% | 11.88% | 14.98% | 13.03% | 11.75% | 11.54% | 11.06% | 10.82% |
Category Average | 2.20% | 36.20% | 36.20% | 17.12% | 57.83% | 53.47% | 38.12% | 12.56% | 13.75% | 12.62% | 10.87% | 10.35% | 9.48% | 8.78% |
Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Return % | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | 3.83% | -0.44% | 43.75% | -4.77% | 0.40% | -33.37% | -17.87% | -6.42% | 43.25% | -3.25% | 51.27% | 15.09% |
Benchmark | 3.15% | 0.85% | 6.37% | -3.27% | 3.48% | -0.40% | -1.51% | -0.10% | 5.56% | 2.91% | 1.69% | 4.96% |
51.27% (July 2025)
-33.37% (February 2025)
Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | - | - | - | - | 86.56% | 55.55% |
Benchmark | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% |
Category Average | -0.60% | 6.48% | 4.63% | -4.48% | 6.64% | 14.43% | 7.75% | -45.86% | 66.56% | 58.00% |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
Category Rank | - | - | - | - | - | - | - | - | - | - |
86.56% (2023)
55.55% (2024)
Name | Percent |
---|---|
Commodities | 100.00 |
Cash and Equivalents | 0.00 |
Name | Percent |
---|---|
Cash and Cash Equivalent | 0.00 |
Other | 100.00 |
Name | Percent |
---|---|
North America | 0.00 |
Other | 100.00 |
Name | Percent |
---|---|
ETHEREUM | - |
Cash and Cash equivalents | - |
Standard Deviation | - | - | - |
---|---|---|---|
Beta | - | - | - |
Alpha | - | - | - |
Rsquared | - | - | - |
Sharpe | - | - | - |
Sortino | - | - | - |
Treynor | - | - | - |
Tax Efficiency | - | - | - |
Volatility | - | - | - |
Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
---|---|---|---|---|
Standard Deviation | 90.25% | - | - | - |
Beta | 5.80% | - | - | - |
Alpha | -0.46% | - | - | - |
Rsquared | 0.44% | - | - | - |
Sharpe | 0.98% | - | - | - |
Sortino | 2.25% | - | - | - |
Treynor | 0.15% | - | - | - |
Tax Efficiency | 100.00% | - | - | - |
Start Date | September 26, 2022 |
---|---|
Instrument Type | Exchange Traded Fund (Alternative) |
Share Class | Do-It-Yourself |
Legal Status | - |
Sales Status | Open |
Currency | CAD |
Distribution Frequency | Annual |
Assets ($mil) | - |
52 Week High | $89.48 |
52 Week Low | $27.38 |
Annual Dividend | - |
Annual Yield | - |
Index | - |
Shares Outstanding | - |
Registered Plan Eligible | Yes |
Exposure | - |
---|---|
Asset Class High | - |
Asset Class Medium | - |
Asset Class Low | - |
Leveraged | - |
Inverse | - |
Advisor Series | - |
Covered Call Strategy | No |
Fidelity Advantage Ether ETF™ aims to invest in ether.
In order to achieve its investment objective, Fidelity Advantage Ether ETF™ invests primarily in ether. The direct long-term holdings of ether are purchased or received by Fidelity Advantage Ether ETF™ only from Acceptable Bitcoin/Ether Sources. Each Acceptable Bitcoin/Ether Source is a spot market where ether can be exchanged for U.S. or, in some cases, Canadian dollars.
Portfolio Manager |
Fidelity Investments Canada ULC
|
---|---|
Sub-Advisor |
- |
Fund Manager |
Fidelity Investments Canada ULC |
---|---|
Custodian |
- |
Registrar |
- |
Distributor |
- |
MER | 0.53% |
---|---|
Management Fee | 0.40% |
Try Fund Library Premium
For Free with a 30 day trial!